Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 16.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 12,200 shares of the biotechnology company’s stock after purchasing an additional 1,700 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Axon Enterprise were worth $7,251,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after purchasing an additional 18 shares during the last quarter. Bleakley Financial Group LLC increased its position in shares of Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC increased its position in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its position in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC increased its position in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.6 %

Axon Enterprise stock opened at $499.73 on Tuesday. The firm has a 50-day moving average price of $616.95 and a two-hundred day moving average price of $520.78. The firm has a market capitalization of $38.11 billion, a price-to-earnings ratio of 129.13, a PEG ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 52-week low of $265.32 and a 52-week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the sale, the insider now directly owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 8,711 shares of company stock valued at $5,631,561. Company insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on AXON shares. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday, February 20th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.